2020
DOI: 10.1186/s12931-020-01550-6
|View full text |Cite
|
Sign up to set email alerts
|

Are there pulmonary sequelae in patients recovering from COVID-19?

Abstract: It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from coronavirus disease 2019 (COVID-19). In this observational study, hospitalized patients with COVID-19 had a HRCT of the chest performed to detect the extension of fibrotic abnormalities via Hounsfield Units (HU). At follow-up, the lung density significantly improved in both lungs and in each lobe of all patients, being in the normal range (− … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
37
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 10 publications
1
37
0
1
Order By: Relevance
“…So this may raise an important question for doctors: are there any long-term pulmonary sequelae in patients recovering from COVID-19? Up to now, few reports have described the sequelae of COVID-19 survivors (5)(6)(7)(17)(18)(19)(20), and the long-term radiological changes have not been well-studied. In our study, we presented the results of 7-month follow-up chest CT in patients with COVID-19, and we compared clinical data and chest CT between patients with or without pulmonary fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…So this may raise an important question for doctors: are there any long-term pulmonary sequelae in patients recovering from COVID-19? Up to now, few reports have described the sequelae of COVID-19 survivors (5)(6)(7)(17)(18)(19)(20), and the long-term radiological changes have not been well-studied. In our study, we presented the results of 7-month follow-up chest CT in patients with COVID-19, and we compared clinical data and chest CT between patients with or without pulmonary fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Pulmonary sequelae in survivors from COVID-19 pneumonia have been a matter of intense discussion [ 16 , 34 ]. In fact, all studies, but one [ 12 ], performed a single lung functional assessment [ 9 , 10 , 11 , 13 , 14 , 15 , 16 ], limiting any hypothesis on the potential evolution and determinants of lung function impairment in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…The radiological evolution of COVID-19 pneumonia during the acute phase of the disease has been extensively studied [ 7 , 8 ], but the pathophysiological and clinical impact of potential pulmonary sequelae is still under investigation. Some line of evidence suggested that thirty days from discharge the CT abnormalities resolve almost completely in mild to moderate COVID-19 forms [ 9 ]. Other Authors, however, reported that in patients with moderate, severe and critical disease, both ground glass opacities and septal thickening tend to persist up to three months post-discharge [ 8 , 10 , 11 , 12 , 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Those who recover might survive with lung fibrosis as sequelae and are more prone to re-infection and subsequent respiratory compromise. 1,2 Although clinically diverse, and as previous researches have opined, these infections are propagated through the atmospheric conditions of the ambient environment. 3,4 One such condition is air pollution that may alter the respiratory tract through inflammation resulting in diseases like COPD and Bronchial Asthma.…”
Section: Introductionmentioning
confidence: 99%